(Q39379516)

11 September 2017

title

Hodgkin's lymphoma RNA-transfected dendritic cells induce cancer/testis antigen-specific immune responses (English)

1 reference

11 September 2017

1 reference

10

1 reference

11 September 2017

7

Alexander Emmer

1 reference

11 September 2017

8

Malte Kornhuber

1 reference

11 September 2017

Carolin Winkler

1

1 reference

11 September 2017

Daniel Sebastian Steingrube

2

1 reference

11 September 2017

Wolfgang Altermann

3

1 reference

11 September 2017

Gerald Schlaf

4

1 reference

11 September 2017

Daniela Max

5

1 reference

11 September 2017

Stefanie Kewitz

6

1 reference

11 September 2017

Ursula Banning-Eichenseer

9

1 reference

11 September 2017

publication date

15 March 2012

1 reference

Cancer Immunology, Immunotherapy

11 September 2017

published in

1 reference

11 September 2017

volume

61

1 reference

11 September 2017

issue

10

1 reference

11 September 2017

page(s)

1769-1779

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-012-1239-z

11 September 2017

exact match

0 references

cites work

Hodgkin and Reed-Sternberg cell-associated autoantigen CLIP-170/restin is a marker for dendritic cells and is involved in the trafficking of macropinosomes to the cytoskeleton, supporting a function-based concept of Hodgkin and Reed-Sternberg cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

The concept of the GPOH-HD 2003 therapy study for pediatric Hodgkin's disease: evolution in the tradition of the DAL/GPOH studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Adoptive immunotherapy for Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

New developments in dendritic cell-based vaccinations: RNA translated into clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Functional and molecular characterization of interleukin-2 transgenic Ewing tumor cells for in vivo immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Phase 1 trial of allogeneic gene-modified tumor cell vaccine RCC-26/CD80/IL-2 in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Gene expression profiles of Hodgkin's lymphoma cell lines with different sensitivity to cytotoxic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Establishment of a human medulloblastoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Hodgkin's disease: establishment and characterization of four in vitro cell lies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Hodgkin's disease derived cell lines HDLM-2 and L-428: comparison of morphology, immunological and isoenzyme profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Loss of detectability of Charcot-Leyden crystal protein transcripts in blood cells after treatment with dimethyl sulfoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Membrane-associated phospholipase A1 beta (LIPI) Is an Ewing tumour-associated cancer/testis antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Retinoic acid enhances sensitivity of neuroblastoma cells for imatinib mesylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Gapped BLAST and PSI-BLAST: a new generation of protein database search programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Genesis: cluster analysis of microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Gene expression analyses reveal molecular relationships among 20 regions of the human CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

High-level expression of Mastermind-like 2 contributes to aberrant activation of the NOTCH signaling pathway in human lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

EBV-positive Hodgkin lymphoma is associated with suppression of p21cip1/waf1 and a worse prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Expression of CD4 on Epstein-Barr virus-immortalized B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Elevated expression levels of testis-specific genes TEX101 and SPATA19 in basal cell carcinoma and their correlation with clinical and pathological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Expression of cancer testis antigen CT45 in classical Hodgkin lymphoma and other B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

The International HapMap Project Web site

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Efficient identification of novel HLA-A(*)0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Identification of HLA class I-restricted tumor-associated antigens in adult T cell leukemia cells by mass spectrometric analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Unique human tumor antigens: immunobiology and use in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Identification and gene structure of a novel human PLZF-related transcription factor gene, TZFP

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Identification of multiple antigens recognized by tumor-infiltrating lymphocytes from a single patient: tumor escape by antigen loss and loss of MHC expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Aberrant hypomethylation of the cancer-testis antigen PRAME correlates with PRAME expression in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

Tumor mRNA-transfected dendritic cells stimulate the generation of CTL that recognize neuroblastoma-associated antigens and kill tumor cells: immunotherapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1239-Z

10.1007/S00262-012-1239-Z

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference